Alcon Inc ALC

$74.79 -0.47 (-0.62%)

Valuation

Market cap
36,655,992,000
Revenue TTM
$10,401,000,000
Net income TTM
$980,000,000
P/E (trailing)
21.79
P/E (forward)
21.17
Profit margin
9.42%
Debt to equity
0.22

Trading

Volume
2,890,063
Avg volume
2,136,598
Day's range
$74.59 – $75.92
Shares out
494,616,000
Stochastic %K
92%
Beta
0.87
Analysts
Moderate Buy
Price target
$80.79

Price

Company profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical proced...

Show more

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Industry
Medical Instruments & Supplies
Sector
Healthcare
Phone
41 589 112 110
Website
https://www.alcon.com
Address
Chemin de Blandonnet 8, Vernier, Geneva, Switzerland

Latest news

Stocktwits

AdamBrennan2 Nov 18, 11:07 AM
$BTMD sells the training and tools that help doctors run hormone pellet therapy practices, and the peer table shows something odd biote isnt even in the visible rows, which are big names like medtronic and boston scientific. the median in this group is 19.1x ebitda and 34x p/e to me that is a high bar for a small niche company to be measured against it looks like a different kind of business than a medical device maker $BSX $ALC $RMD $GEHC
0 replies
PantySniffer69420 Nov 13, 10:19 PM
$ALC 86.01 if the old lady can wait on the burkin bag.
0 replies
STUnusualVolume Nov 11, 3:15 PM
$ALC is trading at 4.2x its normal volume for this time of day.
0 replies
EarningsInsider Nov 11, 2:17 PM
https://www.marketbeat.com/earnings/reports/2026-11-10-alcon-inc-stock/ $ALC Alcon Earnings Transcript
0 replies
TradeWithInsight Nov 11, 1:00 PM
$CRWV is up about 15% premarket and $ALC is down about 3%. Both reported after Tuesday's close. CoreWeave beat on revenue, raised its 2026 outlook and said customer prepayments, not new unsecured debt, will fund most of its build through 2027. Alcon's sales grew 5% and it warned of a tighter eye-care market, which raised growth worries. $CRWV is near 56, just under the 57 high from Oct 30. $ALC is near 71.70, back below the 72.35 low from before its Nov 4 gap up. We go through the earnings movers like this live in the room every morning before the open. Try it free for 2 days: tradewithinsight.com/trial
0 replies
TradeWithInsight Nov 11, 12:08 PM
$CRWV is up about 16% premarket after earnings, with a new financing plan easing debt worries, $NBIS is up about 14% on the CoreWeave read-through and $ALC is down about 4% on light Q3 sales growth. ES futures ranged 7548 to 7616 overnight and sit near 7610, at the top of that range. Nasdaq futures are up about 2%. Veterans Day, times ET: stocks are open and the bond market is closed, 7:00 AM MBA mortgage applications, and $CSCO and $AMAT report Thursday after the close. Morning Report with our levels lands around 9 AM ET.
0 replies
Momentum_trade Nov 11, 11:59 AM
$ALC -5% after the print - management sees a tighter eye-care market and that's a growth story getting slower. On a day when everything AI is green, money doesn't need to sit here. Bounces into VWAP are where I'd look. Not financial advice
1 replies
algotradealert Nov 11, 11:56 AM
$ALC Q3 core EPS was $0.91 on $2.72B revenue; shares were down 5.16% in the supplied NYSE premarket report. Watch growth and execution as Alcon narrows its 2026 outlook. Supplied chart: SIX listing, CHF.
0 replies